jRCTs051180218已完成不适用
Phase II clinical trial on clinical efficacy and safety of combination therapy of boron neutron capture therapy and bevacizumab for recurrent glioma with poor prognosis (P2BNCTBforrMG)
未提供0 个研究点目标入组 20 人开始时间: 2017年10月2日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 主要终点
- Overall survival OS
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 15age old over 至 84age old under（—）
- 性别
- All
入选标准
- •See the attached file.
排除标准
- •See the attached file.
结局指标
主要结局
Overall survival OS
It is defined as the period from the treatment start date to the death date due to any cause. In surviving cases, we will terminate halfway with the date of final survival confirmation. In the case of non-follow-up cases, we aborted by the last day that survival was confirmed before becoming impossible to pursue.
次要结局
- PFS by RANO standard
- Expression of adverse events(during treatment or within 30 days after the end of treatment)
研究者
相似试验
招募中
1 期
Boron neutron capture therapy for recurrent and advanced head and neck cancer.head and neck cancer.JPRN-UMIN000011221niversity of Tsukuba10
已完成
不适用
Boron neutron capture therapy for recurrent and refractory breast cancer after X-ray treatment (BNCTonrBC)jRCTs0511802193
招募中
不适用
Boron neutron capture therapy combined with X-ray fractionation and temozolomide for newly-diagnosed malignant gliomamalignant gliomaJPRN-UMIN000003984Department of Neurosurgery,Graduate School of Comprehensive Human Science, University of Tsukuba20
已完成
不适用
Clinical trial of boron neutron capture therapy utilizing research reactor for skin malignant tumorsskin malignant tumorsJPRN-UMIN000027541kawasaki Medical School10
尚未招募
不适用
Boron neutron capture therapy using cyclotron-based epithermal neutron source for squamous cell carcinoma of the head and neck refractory to standard treatments: An open-label phase II trialunresectable squamous cell carcinoma of the head and neck refractory to standard treatmentsJPRN-UMIN000044118Department of Radiation Oncology, Southern Tohoku BNCT Research Center120